Role Of Nuclear Organization In Protecting Genome Stability During Recombination

核组织在重组过程中保护基因组稳定性中的作用

基本信息

  • 批准号:
    8703127
  • 负责人:
  • 金额:
    $ 38.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-11 至 2017-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Tight control of antigen-receptor gene rearrangement is required to preserve genome integrity and prevent the occurrence of damage and translocations that lead to leukemia and lymphoma. Our most recent efforts have focused on identifying the mechanism underlying regulation of RAG cleavage in individual cells. These studies have revealed that higher-order looping and nuclear organization of antigen receptor loci facilitates regulated, coordinated rearrangement in recombination centers. In brief, we discovered that the formation of large higher-order mono-allelic RAG-dependent loops, which separate the 3' end of Tcra from its chromosome territory, correlates with targeting of RAG binding and mono-allelic cleavage in this region. RAG- dependent higher-order looping facilitates RAG-dependent association of homologous (Tcra) and heterologous (Tcra/Igh) antigen receptor alleles at the time of recombination. Moreover, mono-allelic, mono- locus cleavage and the maintenance of genome stability are linked to ATM-mediated regulation of higher- order mono-allelic, mono-locus loop formation and nuclear organization of Tcra and Igh. These data support a model for feedback control of RAG activity occurring in localized recombination centers. In this renewal we aim to expand on our previous findings to further test our model and explore the mechanisms underlying ATM and RAG-mediated control of cleavage. Higher-order looping out of Tcra from the chromosome territory defines a form of looping in recombination that is distinct from the well-known intra-locus looping / contraction tha we and others previously discovered. Thus, our finding adds an entirely new layer of regulation to the rearrangement process. We will examine the relationship between structure and function by performing a detailed analysis of the Tcra/d locus at different stages of development in the presence and absence of RAG. Our approach will be to combine novel experimental and theoretic simulation using high-throughput automated analyses with highest resolution FISH (HTHR-FISH), and high-throughput monitoring of intra/inter chromosomal contacts by chromosome conformation capture (4C-seq). To determine how higher-order looping is integrated with (i) focal RAG binding, (ii) chromatin modifications, (iii) RNA levels and (iv) nuclear accessibility to control RAG cleavage in the interest of preserving genomic stability we will examine the effects of different repair proteins (ATM, 53BP1 and Artemis) in regulating chromosome dynamics of Tcra/d, Igh, Tcrb, and Tcrg (pairing, higher order looping and repositioning to repressive pericentromeric heterochromatin) to control breaks and damage on these loci. This will provide insight into how altered regulation, in the absence of individual repir factors, impacts on the translocation signature of mutant cells. Finally, we aim to determine whether ATM-mediated negative feedback regulation of RAG cleavage involves inhibition of RAG enzymatic activity. !
描述(由申请人提供):需要严格控制抗原-受体基因重排,以保持基因组的完整性,防止导致白血病和淋巴瘤的损害和易位的发生。我们最新的努力集中在确定单个细胞中RAG裂解的潜在调控机制。这些研究表明,抗原受体基因座的高阶环和核组织促进了重组中心受调节的、协调的重排。总之,我们发现,将TCRA的3‘端从其染色体区域分离出来的大的高阶单等位基因RAG依赖环的形成与该区域的RAG结合和单等位基因切割的靶向相关。RAG依赖的高阶环在重组时促进同源(TCRA)和异源(TCRA/IgH)抗原受体等位基因的RAG依赖关联。此外,单等位基因、单基因座的切割和基因组稳定性的维持与ATM介导的对TCRA和IgH的高阶单等位基因、单基因座环的形成和核组织的调节有关。这些数据支持局部重组中心RAG活性的反馈控制模型。在这次更新中,我们的目标是扩大我们之前的发现,以进一步测试我们的模型,并探索ATM和RAG介导的卵裂控制的潜在机制。从染色体区域走出TCRA的高阶环路定义了一种重组中的环路形式,这与我们和其他人以前发现的众所周知的座位内环路/收缩不同。因此,我们的发现为重组过程增加了一层全新的监管。我们将通过在存在和不存在RAG的情况下对不同发育阶段的TCRA/d基因座进行详细分析来研究结构和功能之间的关系。我们的方法将是结合使用高通量自动化分析和最高分辨率FISH(HTHR-FISH)的新颖实验和理论模拟,以及通过染色体构象捕获对染色体内/染色体间接触的高通量监测(4C-SEQ)。为了确定高阶环路如何与(I)焦点RAG结合,(Ii)染色质修饰,(Iii)RNA水平和(Iv)核可及性相结合,以控制RAG切割,以保持基因组稳定性,我们将研究不同修复蛋白(ATM,53BP1和Artemis)在调节TCRA/d,IGH,Tcrb和TCRG染色体动力学中的作用(配对,高阶环和重新定位到抑制着丝粒周围异染色质),以控制这些基因座的断裂和损伤。这将提供洞察,在缺乏个别REPIR因子的情况下,调节改变如何影响突变细胞的易位特征。最后,我们的目的是确定ATM介导的RAG切割的负反馈调节是否涉及对RAG酶活性的抑制。好了!

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yuval Kluger其他文献

Yuval Kluger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yuval Kluger', 18)}}的其他基金

Core C
核心C
  • 批准号:
    10553035
  • 财政年份:
    2022
  • 资助金额:
    $ 38.74万
  • 项目类别:
Core C
核心C
  • 批准号:
    10675116
  • 财政年份:
    2022
  • 资助金额:
    $ 38.74万
  • 项目类别:
Core D: Data Analysis Core
核心D:数据分析核心
  • 批准号:
    10384402
  • 财政年份:
    2021
  • 资助金额:
    $ 38.74万
  • 项目类别:
Core D: Data Analysis Core
核心D:数据分析核心
  • 批准号:
    10689282
  • 财政年份:
    2021
  • 资助金额:
    $ 38.74万
  • 项目类别:
EFFICIENT METHODS FOR CALIBRATION, CLUSTERING, VISUALIZATION AND IMPUTATION OF LARGE scRNA-seq DATA
大规模 scRNA-seq 数据校准、聚类、可视化和插补的有效方法
  • 批准号:
    10335252
  • 财政年份:
    2019
  • 资助金额:
    $ 38.74万
  • 项目类别:
EFFICIENT METHODS FOR CALIBRATION, CLUSTERING, VISUALIZATION AND IMPUTATION OF LARGE scRNA-seq DATA
大规模 scRNA-seq 数据校准、聚类、可视化和插补的有效方法
  • 批准号:
    9920743
  • 财政年份:
    2019
  • 资助金额:
    $ 38.74万
  • 项目类别:
EFFICIENT METHODS FOR CALIBRATION, CLUSTERING, VISUALIZATION AND IMPUTATION OF LARGE scRNA-seq DATA
大规模 scRNA-seq 数据校准、聚类、可视化和插补的有效方法
  • 批准号:
    9764594
  • 财政年份:
    2019
  • 资助金额:
    $ 38.74万
  • 项目类别:
EFFICIENT SPECTRAL APPROACHES FOR FINDING UNDERLYING STRUCTURES IN BIG DATA
用于查找大数据底层结构的高效谱方法
  • 批准号:
    9278252
  • 财政年份:
    2016
  • 资助金额:
    $ 38.74万
  • 项目类别:
Co-ordination of recombination and allelic exclusion at IgH and Igk loci
IgH 和 Igk 位点重组和等位基因排除的协调
  • 批准号:
    8740626
  • 财政年份:
    2014
  • 资助金额:
    $ 38.74万
  • 项目类别:
Role of ATM and RAG in maintaining genome stability during Tcra/d rearrangement.
ATM 和 RAG 在 Tcra/d 重排期间维持基因组稳定性中的作用。
  • 批准号:
    8707743
  • 财政年份:
    2013
  • 资助金额:
    $ 38.74万
  • 项目类别:

相似海外基金

Development of back bone vectors for chimeric antigen receptors against key molecules, CD47 and CD24, activating macrophages
开发针对关键分子 CD47 和 CD24 的嵌合抗原受体的骨干载体,激活巨噬细胞
  • 批准号:
    23K06728
  • 财政年份:
    2023
  • 资助金额:
    $ 38.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CAREER: Engineering next-generation chimeric antigen receptors for cancer immunotherapy using phospho-proteomics
职业:利用磷酸蛋白质组学设计用于癌症免疫治疗的下一代嵌合抗原受体
  • 批准号:
    2145853
  • 财政年份:
    2022
  • 资助金额:
    $ 38.74万
  • 项目类别:
    Continuing Grant
Construction of a drug discovery platform utilizing antigen receptors that regulate the quality of cancer immunity
利用调节癌症免疫质量的抗原受体构建药物发现平台
  • 批准号:
    22K06603
  • 财政年份:
    2022
  • 资助金额:
    $ 38.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Engineering synthetic adhesion receptors to enhance the sensitivity of therapeutic chimeric antigen receptors
工程合成粘附受体以增强治疗性嵌合抗原受体的敏感性
  • 批准号:
    MR/W031353/1
  • 财政年份:
    2022
  • 资助金额:
    $ 38.74万
  • 项目类别:
    Research Grant
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
用于基于自然杀伤细胞的免疫治疗的嵌合抗原受体的基于建模的设计
  • 批准号:
    10701754
  • 财政年份:
    2022
  • 资助金额:
    $ 38.74万
  • 项目类别:
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
用于基于自然杀伤细胞的免疫治疗的嵌合抗原受体的基于建模的设计
  • 批准号:
    10557760
  • 财政年份:
    2022
  • 资助金额:
    $ 38.74万
  • 项目类别:
Chimeric antigen receptors on regulatory T cells as a treatment strategy in auto-immune diseases.
调节性 T 细胞上的嵌合抗原受体作为自身免疫性疾病的治疗策略。
  • 批准号:
    437200
  • 财政年份:
    2020
  • 资助金额:
    $ 38.74万
  • 项目类别:
    Studentship Programs
Molecualr imaging for development of chimeric antigen receptors (CARs) resistant to T cell exhaustion
用于开发抗 T 细胞耗竭的嵌合抗原受体 (CAR) 的分子成像
  • 批准号:
    20H03536
  • 财政年份:
    2020
  • 资助金额:
    $ 38.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
通过干细胞递送治疗性抗 HIV 嵌合抗原受体
  • 批准号:
    10542442
  • 财政年份:
    2020
  • 资助金额:
    $ 38.74万
  • 项目类别:
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
通过干细胞递送治疗性抗 HIV 嵌合抗原受体
  • 批准号:
    10321545
  • 财政年份:
    2020
  • 资助金额:
    $ 38.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了